Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to FAM174B
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
ENSG00000271763 encodes a long non-coding RNA transcript located antisense to the FAM174B gene. Its sequence and genomic orientation are catalogued in databases such as Ensembl and GeneCards, but there are no experimentally verified biological roles, molecular interactions, or disease associations specific to this transcript. Like many lncRNAs, it may have a regulatory function at the RNA level, but neither its physiological nor pathological relevance has been substantiated. It is not considered a receptor, enzyme, transporter, or transcription factor, and is not an established therapeutic target[1]. If you seek structured data regarding druggability, disease relevance, or molecular classification suitable for databases, this entry should be considered an "other" non-coding RNA, with no current evidence for target validation or clinical utility.
- Other names
- ENSG00000271763lncRNA antisense to FAM174BFAM174B-AS
02
Biological functions
No experimentally validated functions; potential regulatory RNA (lncRNAs commonly regulate gene expression)
03
Disease associations
None reported in the literature for this specific transcript; FAM174B itself has possible associations with cell fate modulation, but no evidence links the antisense transcript directly to disease.
04
Safety considerations
no therapeutic interventions targeting this RNA, hence no established safety profile
05
Interacting drugs
None identified; lncRNAs are not typical drug targets, and no interacting compounds have been described for this molecule.
06
Biomarkers
None reported; this transcript is not a validated biomarker for patient selection or disease tracking.
Beyond the preview
Go deeper on Novel transcript, antisense to FAM174B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to FAM174B.